Insider Transactions in Q2 2021 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
2,220
-3.3%
|
$28,860
$13.78 P/Share
|
|
Jun 21
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,220
+3.09%
|
$8,880
$4.84 P/Share
|
|
Jun 01
2021
|
Lawrence M Alleva Director |
BUY
Open market or private purchase
|
Indirect |
1,035
+32.81%
|
$14,490
$14.38 P/Share
|
|
May 20
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
4,102
-6.12%
|
$57,428
$14.1 P/Share
|
|
May 20
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,102
+5.77%
|
$16,408
$4.84 P/Share
|
|
Apr 20
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
4,102
-6.12%
|
$61,530
$15.91 P/Share
|
|
Apr 20
2021
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,102
+5.77%
|
$16,408
$4.84 P/Share
|